Q3 2022 Holdings
Filed 2022-10-28 | 79 holdings | $52.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.1M | 606,608 | 17.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.6M | 543,776 | 16.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.5M | 32,545 | 12.5% |
| Cerus Corp(CERS) | COM | 157085101 | $5.8M | 1,616,459 | 11.2% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $4.2M | 420,000 | 8.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.9M | 149,027 | 5.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.9M | 224,555 | 5.5% |
| Cvrx Inc(CVRX) | COM | 126638105 | $2.9M | 307,920 | 5.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.4M | 186,603 | 4.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.8M | 40,741 | 3.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.5M | 53,275 | 2.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $1.3M | 100,469 | 2.5% |
| Codexis Inc(CDXS) | COM | 192005106 | $881.0K | 145,437 | 1.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $598.0K | 262,090 | 1.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $516.0K | 5,000 | 1.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $17.5K | 1,655,775 | 0.0% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $14.5K | 393,000 | 0.0% |
| Prometheus Biosciences IncPut | COM | 74349U108 | $12.1K | 204,700 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $11.1K | 665,854 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.2K | 300,000 | 0.0% |
| Anavex Life Sciences Corp(AVXL)Put | COM NEW | 032797300 | $9.7K | 942,500 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $9.2K | 324,421 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $9.0K | 2,554,277 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.9K | 245,992 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $8.5K | 2,324,066 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $7.9K | 443,100 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.7K | 994,073 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.7K | 110,000 | 0.0% |
| Veru Inc(VERUEUR)Put | COM | 92536C103 | $6.3K | 550,000 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.3K | 136,126 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $6.3K | 1,136,206 | 0.0% |
| Merus N V | COM | N5749R100 | $5.9K | 295,136 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $5.7K | 983,516 | 0.0% |
| Clene Inc(CLNNEUR)Put | COMMON STOCK | 185634102 | $4.9K | 1,734,800 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.8K | 224,016 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $4.8K | 362,377 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $4.4K | 209,822 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.9K | 56,645 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.9K | 1,208,992 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $3.2K | 11,105 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $3.2K | 177,364 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $3.0K | 42,500 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.9K | 110,085 | 0.0% |
| Lava Therapeutics NV | SHS | N51517105 | $2.8K | 610,809 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $2.4K | 400,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $2.4K | 366,493 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.3K | 10,323 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $2.3K | 300,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.2K | 10,696 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $2.1K | 83,305 | 0.0% |